Abstract:Computational drug repositioning, through predicting drug-disease associations (DDA), offers significant potential for discovering new drug indications. Current methods incorporate graph neural networks (GNN) on drug-disease heterogeneous networks to predict DDAs, achieving notable performances compared to traditional machine learning and matrix factorization approaches. However, these methods depend heavily on network topology, hampered by incomplete and noisy network data, and overlook the wealth of biomedical knowledge available. Correspondingly, large language models (LLMs) excel in graph search and relational reasoning, which can possibly enhance the integration of comprehensive biomedical knowledge into drug and disease profiles. In this study, we first investigate the contribution of LLM-inferred knowledge representation in drug repositioning and DDA prediction. A zero-shot prompting template was designed for LLM to extract high-quality knowledge descriptions for drug and disease entities, followed by embedding generation from language models to transform the discrete text to continual numerical representation. Then, we proposed LLM-DDA with three different model architectures (LLM-DDA Node Feat , LLM-DDA Dual GNN , LLM-DDA GNN-AE ) to investigate the best fusion mode for LLM-based embeddings. Extensive experiments on four DDA benchmarks show that, LLM-DDA GNN-AE achieved the optimal performance compared to 11 baselines with the overall relative improvement in AUPR of 23.22%, F1-Score of 17.20%, and precision of 25.35%. Meanwhile, selected case studies of involving Prednisone and Allergic Rhinitis highlighted the model's capability to identify reliable DDAs and knowledge descriptions, supported by existing literature. This study showcases the utility of LLMs in drug repositioning with its generality and applicability in other biomedical relation prediction tasks.

Deep learning of multimodal networks with topological regularization for drug repositioning

Deep learning of multimodal networks with topological regularization for drug repositioning

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

Deep Multiple Instance Learning on Heterogeneous Graph for Drug-Disease Association Prediction.

Drug Repositioning Method Based on Deep Neural Network

Drug repositioning with adaptive graph convolutional networks

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

deepDR: a network-based deep learning approach to in silico drug repositioning

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

A weighted bilinear neural collaborative filtering approach for drug repositioning

Drug repositioning based on weighted local information augmented graph neural network

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

Heterogeneous multi-scale neighbor topologies enhanced drug-disease association prediction

A geometric deep learning framework for drug repositioning over heterogeneous information networks

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning

REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction

Empowering Graph Neural Network-Based Computational Drug Repositioning with Large Language Model-Inferred Knowledge Representation

Multiscale topology in interactomic network: from transcriptome to antiaddiction drug repurposing

Enhancing Drug Repositioning through Local Interactive Learning with Bilinear Attention Networks